SHE:300584 - Nanjing Hicin Pharmaceutical Co Ltd

Nanjing Hicin Pharmaceutical C
Sector: Health Care, Industry: Pharmaceuticals

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized

Show %	2015 Q3	2015 Q4	2016 Q1	2016 Q2	2016 Q3	2016 Q4	2017 Q1	2017 Q2	2017 Q3	2017 Q4	2018 Q1	2018 Q2	2018 Q3	2018 Q4	2019 Q1	2019 Q2	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	Graph
Total Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	154.7M -4.6%	136.62M -11.7%	124.79M -8.7%	150.61M 20.7%	116.97M -22.3%	111.63M -4.6%	147.25M 31.9%	117.2M -20.4%	144.35M 23.2%	116.4M -19.4%	139.88M 20.2%	104.56M -25.3%
Cost of Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	26.69M -12.9%	24.56M -8.0%	27.12M 10.4%	40.07M 47.8%	26.57M -33.7%	26.77M 0.7%	36.61M 36.8%	20.81M -43.2%	24.43M 17.4%	23.91M -2.1%	27.46M 14.8%	18.68M -32.0%
Gross Profit	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	128.01M -2.7%	112.06M -12.5%	97.68M -12.8%	110.54M 13.2%	90.4M -18.2%	84.87M -6.1%	110.64M 30.4%	96.4M -12.9%	119.92M 24.4%	92.49M -22.9%	112.43M 21.6%	85.88M -23.6%
Total Expenses	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	145.05M -0.7%	125.64M -13.4%	127.4M 1.4%	131.35M 3.1%	107.57M -18.1%	106.85M -0.7%	135.96M 27.2%	99.87M -26.5%	133.27M 33.4%	110.31M -17.2%	120.62M 9.3%	83.27M -31.0%
Operating Expense	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	118.36M 2.5%	101.08M -14.6%	100.29M -0.8%	91.29M -9.0%	80.99M -11.3%	80.08M -1.1%	99.35M 24.1%	79.07M -20.4%	108.84M 37.7%	86.41M -20.6%	93.16M 7.8%	64.59M -30.7%
Operating Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	9.65M -40.0%	10.98M 13.7%	-2.61M -	19.25M -	9.41M -51.1%	4.79M -49.1%	11.29M 136.0%	17.33M 53.4%	11.08M -36.0%	6.09M -45.1%	19.26M 216.4%	21.29M 10.5%
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	20.7M -	-	-	-	17.4M -	-	-	-	19.47M -	-	-	-
Net Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	7.63M -43.6%	7.1M -6.9%	257.64M 3530.3%	12.62M -95.1%	5.1M -59.6%	2.36M -53.7%	12.37M 423.8%	12.21M -1.2%	7.26M -40.5%	2.95M -59.4%	13.89M 371.4%	13.36M -3.9%
Basic EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	0.064 -43.6%	0.059 -6.8%	2.147 3526.7%	0.105 -95.1%	0.043 -59.6%	0.02 -53.6%	0.103 422.8%	0.102 -1.2%	0.06 -40.6%	0.025 -59.3%	0.116 370.3%	0.111 -3.8%
Diluted EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	0.064 -43.6%	0.059 -6.8%	2.147 3526.7%	0.105 -95.1%	0.043 -59.6%	0.02 -53.6%	0.103 422.8%	0.102 -1.2%	0.06 -40.6%	0.025 -59.3%	0.116 370.3%	0.111 -3.8%